In vivo optical trapping indicates kinesin’s stall force is reduced by dynein during intracellular transport

Kinesin and dynein are fundamental components of intracellular transport, but their interactions when simultaneously present on cargos are unknown. We built an optical trap that can be calibrated in vivo during data acquisition for each individual cargo to measure forces in living cells. Comparing d...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 110; no. 9; pp. 3381 - 3386
Main Authors Blehm, Benjamin H., Schroer, Trina A., Trybus, Kathleen M., Chemla, Yann R., Selvin, Paul R.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 26.02.2013
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Kinesin and dynein are fundamental components of intracellular transport, but their interactions when simultaneously present on cargos are unknown. We built an optical trap that can be calibrated in vivo during data acquisition for each individual cargo to measure forces in living cells. Comparing directional stall forces in vivo and in vitro, we found evidence that cytoplasmic dynein is active during minus- and plus-end directed motion, whereas kinesin is only active in the plus direction. In vivo, we found outward (∼plus-end) stall forces range from 2 to 7 pN, which is significantly less than the 5- to 7-pN stall force measured in vitro for single kinesin molecules. In vitro measurements on beads with kinesin-1 and dynein bound revealed a similar distribution, implying that an interaction between opposite polarity motors causes this difference. Finally, inward (∼minus-end) stalls in vivo were 2–3 pN, which is higher than the 1.1-pN stall force of a single dynein, implying multiple active dynein.
Bibliography:http://dx.doi.org/10.1073/pnas.1219961110
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Edited by James A. Spudich, Stanford University School of Medicine, Stanford, CA, and approved December 26, 2012 (received for review November 21, 2012)
Author contributions: B.H.B. and P.R.S. designed research; B.H.B. performed research; T.A.S., K.M.T., and Y.R.C. contributed new reagents/analytic tools; B.H.B., T.A.S., K.M.T., and Y.R.C. analyzed data; and B.H.B. and P.R.S. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1219961110